Medicinal Products and Pharmaceuticals: Mastering 61-FZ Compliance in 2026 — A Data-Driven Guide

Medicinal Products and Pharmaceuticals: Mastering 61-FZ Compliance in 2026 — A Data-Driven Guide

In 2026, Russia's pharmaceutical sector operates under intensified scrutiny. Federal Law No. 61-FZ "On Circulation of Medicines" remains the cornerstone of regulation, but its enforcement has grown sharper. Roszdravnadzor, the federal health surveillance service, now conducts risk-based inspections with unprecedented frequency. License suspensions and revocations are no longer rare events—they are weekly occurrences. For pharmacy chains, wholesale distributors, and importers, non-compliance can mean not just fines but closure.

Why does this matter to you? Because the rules are complex, the stakes are high, and the consequences are immediate. A single missing document, an unregistered medicine, or a pharmacovigilance lapse can trigger penalties that dwarf your monthly revenue. Yet many professionals still rely on outdated knowledge or informal advice. That's where structured, up-to-date education becomes critical.

The Medicinal Products and Pharmaceuticals course at asibiont.com offers a comprehensive, AI-powered learning path through the entire lifecycle of medicines—from registration to retail sale. It's not just about passing an exam; it's about mastering the legal framework so you can protect your business and advance your career.

Why 61-FZ Compliance Is Non-Negotiable in 2026

Federal Law 61-FZ, originally adopted in 2010, has been amended dozens of times. The 2026 version includes stricter requirements for pharmacovigilance, serialization, and licensing. Roszdravnadzor's inspection results from the first half of 2026 show a clear trend: violations related to documentation and storage conditions account for the majority of penalties.

Consider these realities:

• License suspensions often result from failure to report adverse events within the mandated 15-day window.
• Fines for pharmacies for improper storage of temperature-sensitive medicines can reach 200,000 RUB under Article 14.4 of the Code of Administrative Offences.
• Wholesale distributors face license revocation for repeated violations of wholesale trade rules, as outlined in Decree of the Government of the Russian Federation No. 547.

The data is clear: ignorance is expensive. But navigating the law alone is daunting. The course breaks down each requirement into actionable steps, using real examples and document templates.

What You'll Learn: From Registration to Pharmacovigilance

The Medicinal Products and Pharmaceuticals course covers the full spectrum of pharmaceutical circulation. Here's a breakdown of key modules and the skills you'll gain:

1. State Registration of Medicines

You'll learn the step-by-step process for obtaining a marketing authorization from the Ministry of Health. This includes:

• Preparing the registration dossier (Module 1-5 as per EAEU rules).
• Understanding timelines: standard registration takes up to 160 working days, but accelerated pathways exist for orphan drugs.
• Navigating Roszdravnadzor's expert review and the role of the Ethics Committee.
• Handling variations and renewals.

Practical example: A generic manufacturer submits a dossier with incomplete stability data. The course teaches you how to avoid such pitfalls by using the provided checklist.

2. Pharmaceutical Licensing

Licensing is the gateway to legal operation. You'll explore:

• Types of licenses: production, wholesale, retail, and pharmaceutical activities.
• Requirements for premises, equipment, and personnel.
• The licensing process: application, inspection, and decision.
• Grounds for suspension or revocation, with case studies from 2025-2026.

Document templates: The course includes sample license applications, inspection reports, and compliance logs.

3. Wholesale and Retail Trade Rules

• Wholesale: compliance with Decree No. 547, including storage, transportation, and record-keeping.
• Retail: rules for pharmacy chains, including prescription dispensing, over-the-counter sales, and serialization.
• E-commerce: legal nuances of online pharmacy sales.

Case study: A pharmacy chain was fined 1.2 million RUB for selling prescription drugs without a valid prescription. The course dissects this case to illustrate common mistakes.

4. Pharmacovigilance

Pharmacovigilance is a rapidly evolving area. You'll learn:

• How to set up a pharmacovigilance system (PV system) as required by Roszdravnadzor.
• Reporting adverse drug reactions (ADRs) using the national database.
• Periodic safety update reports (PSURs) and risk management plans.
• The role of the Qualified Person for Pharmacovigilance (QPPV).

Real-world scenario: A company fails to report a serious ADR within 15 days, leading to a 500,000 RUB fine. The course shows you how to implement internal reporting procedures to prevent this.

5. Liability and Inspections

• Administrative and criminal liability for violations.
• Preparing for Roszdravnadzor inspections.
• Responding to inspection findings and appeals.

Checklist: A comprehensive pre-inspection checklist is provided, covering documentation, storage, and staff training.

How Learning Works on asibiont.com

asibiont.com is not a traditional online course platform. It leverages artificial intelligence to generate personalized lessons for each student. When you enroll in Medicinal Products and Pharmaceuticals, the AI assesses your current knowledge, your goals, and your learning pace. It then creates a unique sequence of text-based lessons tailored to you.

Key features:

• AI-generated lessons: No two students see the same course. If you're a pharmacist needing to brush up on retail rules, the AI emphasizes that. If you're a regulatory affairs specialist, it dives deeper into registration dossiers.
• Text-based format: All lessons are written in clear, concise language. You can read at your own speed, anytime, anywhere. There are no videos to stream—just focused, expert-written content.
• 24/7 access: The platform is available around the clock. You can log in at 2 AM and continue where you left off.
• Interactive exercises: Each lesson includes practical tasks, such as drafting a pharmacovigilance report or analyzing a license application. The AI provides instant feedback and explanations.
• Adaptive difficulty: If you struggle with a concept, the AI offers additional explanations and simpler examples. If you excel, it moves you to advanced topics.

Why AI learning is modern and effective:

Traditional courses are one-size-fits-all. They bore experts and overwhelm beginners. AI-driven learning solves this by continuously adapting. The neural network behind asibiont.com analyzes your responses and adjusts the content in real time. It explains complex legal terms in plain English (or Russian, depending on your preference) and provides relevant examples from current enforcement practice.

Moreover, the AI stays updated with the latest amendments to 61-FZ and Roszdravnadzor's guidance. You won't study outdated rules. The system pulls from official sources, ensuring accuracy.

Who Is This Course For?

The Medicinal Products and Pharmaceuticals course is designed for a wide range of professionals:

• Pharmacy managers and owners: Ensure your pharmacy passes inspections and avoids fines.
• Regulatory affairs specialists: Master the registration process and variations.
• Quality assurance and pharmacovigilance personnel: Build robust PV systems.
• Wholesale distributors: Comply with complex storage and transportation rules.
• Legal consultants: Advise clients on pharmaceutical law.
• Students and career changers: Gain a competitive edge in the pharmaceutical job market.

No prior legal background is required. The AI starts with fundamentals and gradually builds up to advanced topics. If you're already experienced, you can skip ahead or focus on specific areas.

Practical Tools You'll Use

The course includes a library of document samples that you can download and adapt:

• License application forms.
• Declarations of conformity.
• Pharmacovigilance reporting templates.
• Prescription logs and audit trails.
• Inspection preparation checklists.

These are not generic templates—they are based on real documents that have been accepted by Roszdravnadzor. Using them can save you hours of drafting and reduce the risk of rejection.

Real Results: What Students Achieve

Graduates of the course report tangible outcomes:

• Passing Roszdravnadzor inspections without a single violation.
• Reducing the time to prepare registration dossiers by half.
• Implementing pharmacovigilance systems that meet EAEU standards.
• Avoiding fines that could have reached hundreds of thousands of rubles.

One student, a pharmacy owner in Moscow, used the course's checklist to identify a missing temperature log. She corrected it before an inspection, saving her business from a 150,000 RUB fine. Another, a regulatory specialist, streamlined her company's registration process using the AI-generated lessons on dossier preparation.

The Bottom Line

Pharmaceutical regulation in Russia is not getting simpler. It's becoming more granular, more digital, and more strictly enforced. To thrive, you need more than occasional updates—you need a deep, practical understanding of 61-FZ and its implementing regulations. The Medicinal Products and Pharmaceuticals course at asibiont.com delivers that understanding through a personalized, AI-driven curriculum. It's flexible, thorough, and grounded in real-world enforcement data.

Whether you're looking to protect your business, advance your career, or simply stay compliant, this course gives you the tools and knowledge to succeed. Don't wait for the next inspection to expose a gap. Start learning today.

Enroll in Medicinal Products and Pharmaceuticals and take control of your compliance journey.